Dermatology Physicians of Connecticut

4 Corporate Drive
Shelton, Connecticut 06484

We've found

1 trials

at this facility

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

Status: Enrolling, Phase IV
Updated: 12/31/1969

from

Shelton, CT

Use our guide to learn which trials are right for you!